Φορτώνει......
Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?
Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of chronic liver disease in Western countries, accounting for 20–30% of general population and reaching a prevalence of 55% in patients with type 2 diabetes mellitus (T2DM). Insulin resistance plays a key role in pathogenic mechanism...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Pharmaceuticals (Basel) |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
MDPI
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6316860/ https://ncbi.nlm.nih.gov/pubmed/30413050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph11040121 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|